The guidelines state the recommended first choice pharmacologic therapy, an alternative choice and other possible treatments for each category: A—‘low risk, less symptoms’; B—‘low risk, more symptoms’ ...
Socioeconomic factors, including education and employment status, along with clinical parameters, such as modified Medical Research Council (mMRC) dyspnea scale and Charlson Comorbidity Index (CCI) ...
Patient-reported symptoms in chronic obstructive pulmonary disease may contribute information that can be used to infer future exacerbations and related costs. Patient-reported symptoms in chronic ...
More than 50% of adults with low pulmonary function are undiagnosed and unaware that they have COPD. Alpha-1 antitrypsin deficiency (AATD) is also a rare genetic disorder that causes COPD. 4 Alpha-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results